发明名称 QUINOLINE DERIVATIVE HAVING TLR INHIBITORY ACTIVITY
摘要 <p>A compound represented by general formula (1), a salt of the compound, or a solvate of the compound or the salt, which can inhibit TLR3, 7 and/or 9 and has an excellent prophylactic and/or therapeutic effect on autoimmune diseases, inflammations, allergies, asthma, graft rejection, GvHD or cardiomyopathy associated with sepsis. A: a (substituted) 5- to 6-membered saturated nitrogen-containing heterocyclic ring; Y: a bond or a phenylene group; Z: a bond, a C1-6 alkylene group, N-R7 or O; R1, R3 and R5 to R8: H, a C1-3 alkyl group or the like; R7: H, a C1-6 alkyl group or a 2-nitrobenzenesulfonyl group; and R2 and R4: one represents R8 and the other represents a group represented by formula (2) (wherein B: a (substituted) carbocyclic/heterocyclic ring, W: a C2-6 alkenylene group or the like, X, V: a bond, C(O)NH, NHC(O) or the like, and U: a bond or a C1-6 alkylene group; wherein a case in which each of X, V and U is a bond is excluded).</p>
申请公布号 WO2014034719(A1) 申请公布日期 2014.03.06
申请号 WO2013JP72999 申请日期 2013.08.28
申请人 KOWA COMPANY, LTD. 发明人 TAKEMURA, SHUNJI;MIYAKE, YOSHIHARU;KOUKETSU, AKIYASU;TOKUDA, OKIHISA;ASHIKAWA, MASANORI;NISHIYAMA, TATSUAKI;GODA, SATOSHI;TABUNOKI, YUICHIRO;YAMABI, MASAKI
分类号 C07D215/38;A61K31/4709;A61K31/496;A61K31/5377;A61P1/04;A61P9/00;A61P11/06;A61P17/06;A61P19/02;A61P25/00;A61P29/00;A61P31/04;A61P37/02;A61P37/06;A61P37/08;A61P43/00;C07D215/44;C07D215/46;C07D215/48;C07D215/50;C07D215/52;C07D401/12;C07D401/14 主分类号 C07D215/38
代理机构 代理人
主权项
地址
您可能感兴趣的专利